The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC)
- 28 May 2021
- journal article
- research article
- Published by Wiley in Cytopathology
- Vol. 33 (1) , 77-83
Abstract
Objective: Malignant mesothelioma (MM) is usually diagnosed by histological examination of tissue samples; however, effusion cytology offers an opportunity to identify a strong possibility for mesothelioma diagnosis at an early stage. We conducted a retrospective analysis of cytological specimens from a large series of histologically proven MM diagnosed over 19 years. The cases were reviewed and reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).Methods: A total of 450 cases were identified. Cytological analysis was present in 210 patients (164 pleural and 46 peritoneal effusions). All cases were reviewed and reclassified according to the proposed ISRSFC scheme. A comparison among the cytomorphological features was made throughout the different diagnostic categories.Results: The 210 cases were histologically diagnosed as follows: 192 (91.4%) cases had an epithelioid type and 18 (8.6%) had a sarcomatoid subtype of MM. The cytological cases were reclassified as follows: 2 (0.9%) as non‐diagnostic (ND), 81 (38.6%) as negative for malignancy (NFM), 4 (1.9%) as atypia of undetermined significance (AUS), 11 (5.2%) as suspicious for malignancy (SFM), 112 (53.4%) as malignant (MAL). Sarcomatoid cells in the MAL category were characterised cytomorphologically by more pronounced discohesion. In comparison with the epithelioid subtype, the tumour cells appeared solitary with moderate or marked nuclear pleomorphism, and irregular chromatin.Conclusions: It is important to recognise the cytological characteristics of this aggressive entity to suggest an early and precise possible diagnosis. Morphological features, coupled with clinico‐radiological data may help the clinicians in adequately managing the patients.Keywords
This publication has 23 references indexed in Scilit:
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest GroupArchives of Pathology & Laboratory Medicine, 2013
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- Predicting survival in malignant mesotheliomaEuropean Respiratory Journal, 2011
- The Diagnostic Utility ofp16FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial ProliferationsAmerican Journal of Clinical Pathology, 2011
- The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesotheliomaDiagnostic Cytopathology, 2010
- Fluorescence In Situ Hybridization in the Definitive Diagnosis of Malignant Mesothelioma in Effusion CytologyChest, 2010
- Histologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated With Extrapleural PneumonectomyAmerican Journal of Clinical Pathology, 2008
- 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysisCancer, 2008
- The Role of Cytologic Evaluation of Pleural Fluid in the Diagnosis of Malignant MesotheliomaChest, 1997
- Cytopathology of malignant mesothelioma: A study of its patterns and histological basesDiagnostic Cytopathology, 1993